Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Debt / NOTE 0.599% 8/0
-
Number of holders
-
50
-
Total 13F principal, excl. options
-
366,553,882
-
Principal change
-
-116,747,118
-
Total reported value, excl. options
-
$388,746,400
-
Value change
-
-$116,441,443
-
Number of buys
-
22
-
Number of sells
-
19
-
Price
-
$1.06
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 as of Q4 2019
As of 31 Dec 2019 BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 had 50 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $366,553,882 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included ADVENT CAPITAL MANAGEMENT /DE/, MACKAY SHIELDS LLC, LAZARD ASSET MANAGEMENT LLC, SHENKMAN CAPITAL MANAGEMENT INC, JPMORGAN CHASE & CO, STATE STREET CORP, BAKER BROS. ADVISORS LP, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, BANK OF AMERICA CORP /DE/, and SONORA INVESTMENT MANAGEMENT, LLC.
This table shows 50 bond principal holders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.